Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: A systematic review of the clinical experience with thalidomide

Journal of Thrombosis and Thrombolysis

Volumn 36, Issue 3, 2013, Pages 355-357

  Franchini, Massimo ^a   Frattini, Francesco ^a   Crestani, Silvia ^a   Bonfanti, Carlo ^a  

^a CARLO POMA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ENDOGLIN; THALIDOMIDE; TRANEXAMIC ACID; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; CONSTIPATION; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DROWSINESS; DRUG EFFICACY; DRUG RESPONSE; EPISTAXIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETHARGY; LETTER; LIBIDO DISORDER; PERIPHERAL EDEMA; PRIORITY JOURNAL; QUALITY OF LIFE; RENDU OSLER WEBER DISEASE; RISK REDUCTION; SYSTEMATIC REVIEW;

EPISTAXIS; HUMANS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 84881223902     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0840-5     Document Type: Letter

References (19)

1. Sharathkumar AA, Shapiro A (2008) Hereditary haemorrhagic telangiectasia. Haemophilia 14:1269-1280
2. Govani FS, Shovlin CL (2009) Hereditary haemorrhagic telangiectasia: A clinical and scientific review. Eur J Hum Genet 17:860-871
3. Dupuis-Girod S, Bailly S, Plauchu H (2010) Hereditary hemorrhagic telangiectasia: from molecular biology to patient care. J Thromb Haemost 8:1447-1456
4. McDonald J, Bayrak-Toydemir P, Pyeritz RE (2011) Hereditary hemorrhagic telangiectasia: An overview of diagnosis, management, and pathogenesis. Genet Med 13:607-616
5. Geisthoff UW, Fiorella ML, Fiorella R (2006) Treatment of recurrent epistaxis in HHT. Curr Pharm Des 12:1237-1242
6. Jameson JJ, Cave DR (2004) Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 114:705-709
7. Sabbà C, Gallitelli M, Palasciano G (2001) Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. N Engl J Med 345:926
8. Zarrabeitia R, Albiñana V, Salcedo M, Señaris-Gonzalez B, Fernandez-Forcelledo JL, Botella LM (2010) A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT). Curr Vasc Pharmacol 8:473-481
9. Shovlin CL (2010) Hereditary hemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment. Blood Rev 24:203-219
10. Dupuis-Girod S, Ginon I, Saurin JC et al (2012) Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA 307:948-955
11. Simonds J, Miller F, Mandel J, Davidson TM (2009) The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 119:988-992
12. Chen CH, Hsu HH, Hu RH, Lee PH, Ho CM (2012) Long-term therapy with thalidomide in hereditary hemorrhagic telangiectasia: Case report and literature review. J Clin Pharmacol 52:1436-1440
13. Kurstin R (2002) Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease. Oncology (Williston Park) 16:21-24
14. Kersemaekers MAH, Westermann CJJ, Mager JJ, De Weerdt O, Disch FJM, Snijder RJ (2007) Thalidomide for the treatment of epistaxis in hereditary hemorrhagic telangectasia. Hematol Meet Rep 1:22-23
15. Buscarini E, Manfredi G, Gazzaniga P et al.; on behalf of HHT-NET (2009) Thalidomide for treatment of chronic severe bleeding in hereditary hemorrhagic telangiectasia. Hematol Meet Rep 3:20-21
16. Gossage JR, Chamberlain SM, Sridhar S, Kumar A (2009) An interim report of thalidomide for treatment of recurrent angioectasia related gastrointestinal bleeding. Hematol Meet Rep 3:21
17. Lebrin F, Srun S, Raymond K et al (2010) Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 16:420-428
18. Penaloza A, Vekemans MC, Lambert C, Hermans C (2011) Deep vein thrombosis induced by thalidomide to control epistaxis secondary to hereditary haemorrhagic telangiectasia. Blood Coagul Fibrinolysis 22:616-618
19. Balduini CL, Pagella F, Bellistri F et al (2012) Efficacy of thalidomide in the treatment of severe recurrent epistaxis in hereditary hemorrhagic telangectasia (HHT): ongoing results of a prospective study. Blood Transfus 10(4):s36